Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.67
-0.11 (-0.74%)
Feb 13, 2026, 3:00 PM CST

SHA:600535 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21,91622,51421,60325,42715,98823,778
Market Cap Growth
3.24%4.22%-15.04%59.04%-32.76%6.62%
Enterprise Value
19,48020,07819,11624,80615,10323,396
Last Close Price
14.6715.0714.0815.849.8013.98
PE Ratio
19.8220.3722.6123.74-10.08
Forward PE
12.5412.9415.727.474.038.30
PS Ratio
2.662.732.542.931.852.99
PB Ratio
1.751.801.782.001.261.79
P/TBV Ratio
1.901.951.912.161.341.93
P/FCF Ratio
--14.9013.348.5310.67
P/OCF Ratio
--10.729.877.018.49
PEG Ratio
-1.801.801.801.801.80
EV/Sales Ratio
2.372.442.252.861.752.94
EV/EBITDA Ratio
11.1511.4910.4312.758.5114.20
EV/EBIT Ratio
14.4314.8713.3117.2211.2718.83
EV/FCF Ratio
--13.1913.018.0510.49
Debt / Equity Ratio
0.070.070.140.220.170.13
Debt / EBITDA Ratio
0.490.490.871.461.170.98
Debt / FCF Ratio
--1.151.491.160.76
Net Debt / Equity Ratio
-0.21-0.21-0.15-0.15-0.16-0.16
Net Debt / EBITDA Ratio
-1.51-1.51-1.01-0.99-1.16-1.27
Net Debt / FCF Ratio
---1.28-1.01-1.10-0.94
Asset Turnover
--0.540.520.520.48
Inventory Turnover
--1.621.762.041.85
Quick Ratio
--2.342.913.544.10
Current Ratio
--3.113.694.314.99
Return on Equity (ROE)
8.98%8.98%6.93%8.02%-2.68%18.74%
Return on Assets (ROA)
--5.66%5.43%5.08%4.70%
Return on Invested Capital (ROIC)
11.28%11.06%10.98%11.22%12.28%9.04%
Return on Capital Employed (ROCE)
--11.40%10.00%9.40%8.50%
Earnings Yield
5.04%4.91%4.42%4.21%-1.65%9.92%
FCF Yield
--6.71%7.50%11.73%9.38%
Dividend Yield
3.61%-3.76%2.08%3.37%2.36%
Payout Ratio
--109.09%52.59%-25.88%
Buyback Yield / Dilution
0.01%0.01%-0.43%-1.34%2.29%-0.08%
Total Shareholder Return
3.62%0.01%3.34%0.75%5.66%2.27%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.